GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
Z20.828
Contact with and (suspected) exposure to other viral communicable diseases
ICD10CM code
Medical Policies and Guidelines for Contact with and (suspected) exposure to other viral communicable diseases
Related policies from health plans
CIGNA
COVID-19: In Vitro Diagnostic Testing - (0557)
Similar Codes
ICD10CM codes
Z20.828
- Contact with and (suspected) exposure to other viral communicable diseases
Z20.82
- Contact with and (suspected) exposure to other viral communicable diseases
Z20.8
- Contact with and (suspected) exposure to other communicable diseases
Z20.89
- Contact with and (suspected) exposure to other communicable diseases
Z20.818
- Contact with and (suspected) exposure to other bacterial communicable diseases
Z20.81
- Contact with and (suspected) exposure to other bacterial communicable diseases
Z20.9
- Contact with and (suspected) exposure to unspecified communicable disease
Z20
- Contact with and (suspected) exposure to communicable diseases
Z20.822
- Contact with and (suspected) exposure to COVID-19
Z20.5
- Contact with and (suspected) exposure to viral hepatitis
HCPCS codes
G9416
- Patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the
Q2039
- Influenza virus vaccine, not otherwise specified
U0003
- Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavir
G8482
- Influenza immunization administered or previously received
G8959
- Clinician treating major depressive disorder communicates to clinician treating comorbid condition
U0004
- 2019-nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (i
G0432
- Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, scree
G0472
- Hepatitis c antibody screening, for individual at high risk and other covered indication(s)
U0005
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavir
S8301
- Infection control supplies, not otherwise specified
CPT4 codes
87290
- Infectious agent antigen detection by immunofluorescent technique; Varicella zoster virus
87910
- Infectious agent genotype analysis by nucleic acid (DNA or RNA); cytomegalovirus
87255
- Virus isolation; including identification by non-immunologic method, other than by cytopathic effect
87273
- Infectious agent antigen detection by immunofluorescent technique; Herpes simplex virus type 2
87015
- Concentration (any type), for infectious agents
4037F
- Influenza immunization ordered or administered (COPD, PV, CKD, ESRD)(IBD)
87905
- Infectious agent enzymatic activity other than virus (eg, sialidase activity in vaginal fluid)
4293F
- Patient screened for high-risk sexual behavior (HIV)
87260
- Infectious agent antigen detection by immunofluorescent technique; adenovirus
0240U
- Infectious disease (viral respiratory tract infection), pathogen-specific rna, 3 targets (severe acu